DOCUMENT INFORMATION PAGE

First Page		Document Content
Date: 2010-10-19 08:27:08 Food and Drug Administration Pharmaceutical sciences Medical informatics Structured Product Labeling Pharmaceutical industry Adalimumab Biologic License Application BLA Center for Drug Evaluation and Research Medicine Health Pharmacology		DOCUMENT INFORMATION PAGE Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 41,87 KB Share Document on Facebook

	Microsoft Word - Savient Resubmits Biologics License Application for KRYSTEXXAdoc DocID: 1qqBA - View Document
	Microsoft Word - Savient Update on KRYSTEXXA BLA Filingdoc DocID: 1ot1g - View Document
	PDF Document DocID: 16eHM - View Document
	BLA Complete Response Letter DocID: 14Ctf - View Document
	DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD[removed]MEMORANDUM Date: DocID: XoPt - View Document